Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deals Driving Oncology: ImmunoGen CEO Mark Enyedy on Biopharma’s Year Ahead

Jan 29 2018

• By William Looney

Enyedy_Mark_1200 — Mark Enyedy

Related Companies

ImmunoGen, Inc.

Merck & Co., Inc.

Memorial Sloan Kettering Cancer Center

Sanofi

Genentech, Inc.

Gilead Sciences, Inc.

Kite Pharma, Inc.

Biogen, Inc.

Jazz Pharmaceuticals plc

Denali Therapeutics Inc.

Additional Topics

Deals Leadership Business Strategies BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window